Search

USA: Management Structure Dow Dupont Appoints New Board of Directors for Dupont

| Editor: Ahlam Rais

Dow Dupont has added three more members to the future board of directors of Dupont. The newly appointed directors are Frank K. Clyburn, chief commercial officer at Merck & Co., Terrence R. Curtin, CEO of TE Connectivity, and Frederick M. Lowery, senior vice president and president, Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific.

With the additions, Dupont expects to have 12 members on its board, effective June 1, 2019.
With the additions, Dupont expects to have 12 members on its board, effective June 1, 2019.
(Source: Deposit Photos)

Delaware/USA – Dow Dupont has recently announced three additional members to the future board of directors of Dupont, currently the Specialty Products Division of Dow Dupont. The new directors include Frank K. Clyburn, chief commercial officer at Merck & Co., Terrence R. Curtin, CEO of TE Connectivity, and Frederick M. Lowery, senior vice president and president, Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific. With these additions, Dupont expects to have 12 members on its board, effective June 1, 2019.

Ed Breen, executive chairman-elect of Dupont and current Chair and CEO of Dow Dupont, said, “Dupont’s board of directors is composed of highly qualified leaders, with the right mix of skills and experience to position the independent company to drive sustainable growth. The new directors bring deep global expertise in electronics and pharmaceuticals, as well as manufacturing, further strengthening the overall board. They will also work closely with the management team to oversee the successful execution of Dupont’s strategy and enhance value for shareholders.”

“We’re excited to welcome Frank Clyburn, Terrence Curtin, and Fred Lowery to the future Dupont board,” said Marc Doyle, CEO-elect of DuPont. “Their diverse perspectives and expertise will be invaluable as we leverage our proprietary technology and deep customer relationships to drive innovation in attractive high-growth markets.”

Dow Dupont remains on track to separate the Agriculture Division (Corteva Agriscience) and Specialty Products Division (Dupont) on June 1, 2019.

In addition to Clyburn , Curtin, and Lowery, Dupont’s future board of directors includes: Edward D. Breen, CEO of Dow Dupont and executive chairman-elect of Dupont; Ruby R. Chandy, former president of Industrial Division of Pall Corp.; Alexander M. Cutler, lead independent director of Dow Dupont and former chairman and chief executive officer of Eaton; Marc Doyle, COO of the Specialty Products Division of Dow Dupont and CEO-elect of Dupont; Eleuthère I. du Pont, former president and chief financial officer of Wawa and president of The Longwood Foundation; Rajiv L. Gupta, chairman of Aptiv (formerly Delphi Automotive) and former chairman and CEO of Rohm & Haas; Luther C. Kissam, IV, chairman, president and CEO of Albemarle Corporation; Raymond J. Milchovich, former chairman and CEO of Foster Wheeler; and Steven Sterin, former executive vice president, CFO of Andeavor and former president of Andeavor Logistics.

(ID:45875596)